Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Pharma
J&J's Imaavy wins FDA green light in myasthenia gravis
The FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy as a new treatment for generalized myasthenia gravis.
Fraiser Kansteiner
Apr 30, 2025 10:51am
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
Argenx banks on Vyvgart prefilled syringe approval in 2025: exec
Feb 19, 2025 1:36pm
AZ China fallout, Pfizer's $1B plan in China—Fierce Pharma Asia
Nov 8, 2024 8:54am
Autoimmune drugmaker Aurinia lays off 45% of workforce
Nov 7, 2024 9:44am
Novartis’ Fabhalta wins expanded FDA nod in IgAN
Aug 8, 2024 3:18am
